Skip navigation

Novo Nordisk AS

Pharmaceuticals
Denmark
2016 Revenue (US$ Millions)$15,876
Revenue Growth (%)3.57%
Net Income (US$ Millions)$5,386
Earnings Per Share (US$)$2.12
EPS Growth Rate (%)10.65%
Profit Margin33.93%
Total Equity (US$ Millions)$6,430
Return on Equity (%)80.74%
Long Term Debt (US$ Millions)$0
Debt To Equity Ratio (%)0.00%
Total Assets (US$ Millions)$13,853
Current Assets (US$ Millions)$8,489
Current Liabilities (US$ Millions)$6,737
Cost of Goods Sold (US$ Millions)$2,440
Inventory Turnover1.27